Vasavan Jyothilakshmi Selected Research

phyllanthin

5/2016	Phyllanthin inhibits CCl4-mediated oxidative stress and hepatic fibrosis by down-regulating TNF-α/NF-κB, and pro-fibrotic factor TGF-β1 mediating inflammatory signaling.
1/2015	Mechanism of protective effect of phyllanthin against carbon tetrachloride-induced hepatotoxicity and experimental liver fibrosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasavan Jyothilakshmi Research Topics

Disease

2	Fibrosis (Cirrhosis) 05/2016 - 01/2015
2	Urolithiasis 01/2014 - 07/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Kidney Calculi (Kidney Stone) 01/2014
1	Hyperoxaluria (Oxaluria) 07/2013

Drug/Important Bio-Agent (IBA)

2	phyllanthinIBA 05/2016 - 01/2015
2	Drinking WaterIBA 01/2014 - 07/2013
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2014 - 07/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Activins (Activin)IBA 01/2015
1	CollagenIBA 01/2015
1	Oxidants (Oxidizing Agents)IBA 01/2014
1	Free RadicalsIBA 01/2014
1	AntioxidantsIBA 01/2014
1	EnzymesIBA 07/2013
1	MagnesiumIBA 07/2013